MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1481 to 1500 of 166,322 approvalsPage 75 of 8317

Talquetamab Injection

Approval Number: 国药准字SJ20250004
Registration: Feb 8, 2025

Levocetirizine Dihydrochloride Oral Solution

Approval Number: 国药准字H20253351
Registration: Feb 8, 2025

Lactulose Oral Solution

Approval Number: 国药准字H20253347
Registration: Feb 8, 2025

Piperacillin Sodium for Injection

Approval Number: 国药准字H20253335
Registration: Feb 8, 2025

Ceftolozane Sulfate and Tazobactam Sodium for Injection

Approval Number: 国药准字HJ20250016
Registration: Feb 8, 2025

Glucosamine Sulfate Capsules

Approval Number: 国药准字H20253353
Registration: Feb 8, 2025

Atomoxetine Hydrochloride Capsules

Approval Number: 国药准字H20253340
Registration: Feb 8, 2025

Ilaprazole Enteric-Coated Tablets

Approval Number: 国药准字H20253336
Registration: Feb 8, 2025

Edoxaban Tosilate Tablets

Approval Number: 国药准字H20253356
Registration: Feb 8, 2025

Fluorouracil Injection

Approval Number: 国药准字H20253343
Registration: Feb 8, 2025

Talquetamab Injection

Approval Number: 国药准字SJ20250003
Registration: Feb 8, 2025

Edoxaban Tosilate Tablets

Approval Number: 国药准字H20253355
Registration: Feb 8, 2025

Levocetirizine Dihydrochloride Oral Solution

Approval Number: 国药准字H20253352
Registration: Feb 8, 2025

Diprophylline Injection

Approval Number: 国药准字H20253354
Registration: Feb 8, 2025

Lactulose Oral Solution

Approval Number: 国药准字H20253349
Registration: Feb 8, 2025

Amivantamab Injection

Approval Number: 国药准字SJ20250005
Registration: Feb 8, 2025

Carbocysteine Oral Solution

Approval Number: 国药准字H20253350
Registration: Feb 8, 2025

Roxadustat Capsules

Approval Number: 国药准字H20253332
Registration: Feb 8, 2025

Gabapentin Capsules

Approval Number: 国药准字H20253339
Registration: Feb 8, 2025

Finotonlimab Injection

Approval Number: 国药准字S20250011
Registration: Feb 8, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.